MetaCap

Propanc Biopharma Earnings

NASDAQ: PPCBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.78+0.055 (+3.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Propanc Biopharma earnings summary

In its most recent report on Nov 13, 2026 (Sep/2026), PPCB posted EPS of $-12.22.

Summary generated from market data by MetaCap's automated system. Methodology

PPCB earnings history

Propanc Biopharma reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 13, 2026—$-12.22—-8.3%
Sep 25, 2026—$81.04——
May 14, 2026—$-0.28——
Feb 17, 2026—$-0.30——
Nov 14, 2025—$-98.08——
Sep 29, 2025—$-290.52——
May 15, 2025—$-12.50——
Feb 14, 2025—$-32.23——
Nov 14, 2024—$-35.97——
Sep 30, 2024—$684.85——
May 15, 2024—$-545.79——
Feb 20, 2024—$-1,559.55——
Nov 14, 2023—$-0.04——
Sep 28, 2023—$1.28——
May 15, 2023—$-0.42——
Feb 10, 2023—$-0.53——

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related